BEST UNLIMITED TURBO SHORT CERTIFICATE - ABBOTT LABORATORIES Stock

Certificat

7S31S

DE000SW77TN2

Market Closed - Euronext Paris 12:30:01 2024-05-20 EDT
1.56 EUR +5.41% Intraday chart for BEST UNLIMITED TURBO SHORT CERTIFICATE - ABBOTT LABORATORIES
Current month+20.00%
1 month+21.88%
Date Price Change
24-05-20 1.56 +5.41%
24-05-17 1.48 +4.23%
24-05-16 1.42 -2.07%
24-05-15 1.45 -6.45%
24-05-14 1.55 +7.64%

Real-time Euronext Paris

Last update May 20, 2024 at 12:30 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
7S31S
ISINDE000SW77TN2
Date issued 2024-03-26
Strike 119.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.97
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.59
Lowest since issue 0.59

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
103.2 USD
Average target price
126.1 USD
Spread / Average Target
+22.22%
Consensus
  1. Stock Market
  2. Certificates
  3. 7S31S Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW